Biomerica Reports Second Quarter 2024 Financial Results
January 16, 2024 08:19 ET
|
Biomerica, Inc.
Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023.Loss per shares narrows to $0.09 per share from $0.12 per share...
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
December 18, 2023 07:47 ET
|
Biomerica, Inc.
Over 80% of gastric cancers are attributed to H. pylori bacterial infection Gastric cancer is the third most common cause of cancer related death in the world ...
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
November 10, 2023 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th...
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
November 08, 2023 08:19 ET
|
Biomerica, Inc.
Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rolloutVeteran Vice President of Sales and National...
REPEAT - Biomerica Reports First Quarter 2024 Financial Results
October 13, 2023 13:10 ET
|
Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024
Biomerica Reports First Quarter 2024 Financial Results
October 13, 2023 06:39 ET
|
Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024
Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test
September 26, 2023 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Dubai government has officially approved insurance reimbursement for the EZ...
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
August 28, 2023 08:19 ET
|
Biomerica, Inc.
Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian...
Biomerica Reports Fiscal 2023 Year End Results
August 25, 2023 17:00 ET
|
Biomerica, Inc.
Revenues excluding Covid test sales increased 15% for fiscal 2023 vs fiscal 2022 Successfully completed inFoods® IBS pilot program with one of the largest Gastrointestinal physician groups in the US ...
CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test
August 03, 2023 08:19 ET
|
Biomerica, Inc.
Over 7,000 CVS Pharmacy Stores to sell the EZ Detect™ TestSimple 2 minute at-home test detects an early warning sign of colorectal cancer IRVINE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) --...